Halozyme Therapeutics Inc (NASDAQ:HALO)

Delayed Data
As of Apr 20
 -0.30 / -1.57%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 21.00, with a high estimate of 33.00 and a low estimate of 9.00. The median estimate represents a +11.35% increase from the last price of 18.86.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -123.68%
Growthannually -284.74%


Growthquarterly -81.61%
Growthannually -56.63%
Key to the earnings and sales forecast charts.